CISPLATIN, FLUOROURACIL, MITOMYCIN, CAPECITABINE, CAPECITABINE, DOCETAXEL
PRODIGE85-KANALRAD
Phase 3 small_molecule active
Quick answer
CISPLATIN, FLUOROURACIL, MITOMYCIN, CAPECITABINE, CAPECITABINE, DOCETAXEL for locally advanced anal squamous cell carcinoma is a Phase 3 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- locally advanced anal squamous cell carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active